The need to prevent the accumulation of neurotoxic intermediates such as quinolinic acid likely caused evolutionary pressures favoring high ACMSD activity in humans, which in turn increases pellagra susceptibility. This evidence concerns the gene ACMSD and Vitamin B3 deficiency.